Pfizer (PFE)

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.

One drug developer could be on the cusp of AI-powered glory.

If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

There are plenty of potential winners outside the world of AI.

Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company.

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock.

Roivant (ROIV) Q2 2026 Earnings Call Transcript

These top dividend stocks could intrigue a wide range of investors.

JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season.

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects.

The weight loss drug market may approach almost $100 billion by the end of the decade.

The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the aftershocks of a recent 43-day U.S. government shutdown, which concluded on November 12th, have created an unprecedented "information vacuum." This scarcity of

This big pharma stock should be even more appealing to investors amid market turbulence.

Although the U.S. stock market is trading close to an all-time high, its dividend yield is approaching a 20-year low, and that's creating a challenge for income-oriented investors.

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Copenhagen, Denmark – November 24, 2025 – Novo Nordisk's (CPH: NOVO B) stock experienced a significant and immediate downturn today, plummeting by over 10% in early trading, following the announcement of disappointing results from its highly anticipated late-stage clinical trials for an Alzheimer's disease drug. The trials, which tested an oral formulation

The Schwab U.S. Dividend Equity ETF and Alerian MLP ETF are two nice high-yield ETF options.

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for the market.